Page 1

h

In-Vitro Diagnostics Global Market Report 2018 Including: Point-of-Care Diagnostics; Immunochemistry Diagnostics; Clinical Chemistry Diagnostics; Molecular Diagnostics; Microbiology Diagnostics; Hemostasis Diagnostics; Hematology Diagnostics; Immunohematology Diagnostics Covering: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.), Abbott Laboratories Inc., Thermo Fisher Scientific Inc.

Feb 2018


Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Scope Markets Covered: Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology; Immunohematology Companies Mentioned: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.), Abbott Laboratories Inc., Thermo Fisher Scientific Inc. Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The In-Vitro Diagnostics Market Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


In-Vitro Diagnostics Market Characteristics In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens. Based on techniques, in-vitro diagnostics are classified as follow:

Point-of-Care Diagnostics These devices are designed to aid patients in

Immunochemistry Diagnostics These devices are designed to diagnose diseases or

Clinical Chemistry Diagnostics Clinical chemistry diagnostics are used to

Molecular Diagnostics Molecular Diagnostics are used to


Hematology Diagnostic Instruments Hematology diagnostic instruments are

Microbiology Diagnostic Devices Microbiology diagnostic devices are used to

Hemostasis diagnostics Hemostasis diagnostics are the devices used to

In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.


In-Vitro Diagnostics Market Historic Growth The global in-vitro diagnostics market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global in-vitro diagnostics market during 2013 – 2017.

Drivers of the Market:

Restraints on the Market


In-Vitro Diagnostics Market Forecast Growth The global in-vitro diagnostics market is expected to grow from $XX billion in 2017 to $68 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global in-vitro diagnostics market during 2017 - 2021.

Drivers of the Market

Restraints on the Market


In-Vitro Diagnostics Market Segmentation The chart and table below shows the split of the in-vitro diagnostics market in 2017.

The total market value for in-vitro diagnostics was $X billion in 2017. The markets that are covered include Point-of-Care Diagnostics; Immunochemistry Diagnostics; Clinical Chemistry Diagnostics; Molecular Diagnostics; Microbiology Diagnostic Devices; Hemostasis Diagnostics; Hematology Diagnostic Instruments; Immunohematology Diagnostics Devices Point-of-Care Diagnostics market was the x largest segment in the in-vitro diagnostics market with X% share of the market. The market value for the point-ofcare diagnostics market was $x billion in 2017. Immunochemistry Diagnostics made up around X% share of the market. The market value for the immunochemistry diagnostics was $x billion in 2017.


In-Vitro Diagnostics Market Regional And Country Analysis The Asia Pacific was the x largest region in the in-vitro diagnostics market in 2017, in-vitro diagnostics for $X billion or X% market share. North America was the x largest region in-vitro diagnostics for $X billion or X% market share. South America was the x largest region in-vitro diagnostics for $X billion or X% market share.


In-Vitro Diagnostics Market Competitive Landscape The leading competitors in the global in-vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.), Abbott Laboratories Inc., Thermo Fisher Scientific Inc. The chart and table below displays the percentage market share of the top players in the in-vitro diagnostics market industry.

Siemens Healthineers generated revenues of $XX billion for the financial year 2017, an XX% increase from the previous year. F. Hoffmann-La Roche Ltd generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Danaher (Beckman Coulter Inc) generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Abbott Laboratories Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.


Thermo Fisher Scientific, Inc. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Sysmex Corporation generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. bioMérieux generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Becton Dickinson & Company generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.

Company Profile Siemens Healthineers Overview Siemens Healthineers was the largest company in the in-vitro diagnostics market in 2017 with a XX% share. It provides medical diagnostics solutions, healthcare equipment and related services around the world. Siemens Healthineers formerly known as Siemens Healthcare operates as a subsidiary of Siemens AG and is headquartered in Erlangen, Germany.

Products and Services Siemens Healthineers offers the following products and services

Medical Imaging products – It includes imaging and diagnostic products Laboratory Diagnostics – It consists of immunoassay, hematology, Healthcare IT & Infrastructure Solutions – It provides software and


Strategy Siemens Healthineers’ growth strategy is to strengthen its portfolio across the medical imaging and laboratory diagnostics business while adding new offerings such as managed services, consulting and digital services in the growing market for therapeutic and molecular diagnostics. In the first quarter of 2016, Financial Performance Siemens Healthineers generated revenues of EUR XX billion ($XX billion) for the financial year 2017, a XX% increase from the previous year. Siemens AG had a market F. Hoffmann-La Roche Ltd Overview Products and Services Strategy Financial Performance

Danaher (Beckman Coulter Inc.) Overview Products and Services Strategy Financial Performance

Abbott Laboratories Inc. Overview Products and Services Strategy Financial Performance


Thermo Fisher Scientific Inc. Overview Products and Services Strategy Financial Performance

In-Vitro Diagnostics Global Market Report 2018  

The global in-vitro diagnostics market was valued at around $56 billion in 2017.The USA was the largest country in the market in 2017, accou...

In-Vitro Diagnostics Global Market Report 2018  

The global in-vitro diagnostics market was valued at around $56 billion in 2017.The USA was the largest country in the market in 2017, accou...

Advertisement